User profiles for Erasmus Schneider
 | Erasmus SchneiderResearch Scientist, Wadsworth Center, New York State Department of Health Verified email at wadsworth.org Cited by 6490 |
Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines
…, LV Abruzzo, WS Dalton, E Schneider… - Journal of the …, 1999 - academic.oup.com
BACKGROUND: Human cancer cell lines grown in the presence of the cytotoxic agent
mitoxantrone frequently develop resistance associated with a reduction in intracellular drug …
mitoxantrone frequently develop resistance associated with a reduction in intracellular drug …
Overexpression of wild-type breast cancer resistance protein mediates methotrexate resistance
…, KM Farley, Y Wu, F Li, RW Robey, E Schneider - Cancer research, 2002 - AACR
Previously, we have reported that a multidrug-resistant, mitoxantrone (MX)-selected cell line,
MCF7/MX, is highly cross-resistant to the antifolate methotrexate (MTX), because of …
MCF7/MX, is highly cross-resistant to the antifolate methotrexate (MTX), because of …
Wild-Type Breast Cancer Resistance Protein (BCRP/ABCG2) is a Methotrexate Polyglutamate Transporter
EL Volk, E Schneider - Cancer research, 2003 - AACR
The existence of an ATP-dependent methotrexate (MTX) efflux mechanism has long been
postulated; however, until recently, the molecular components were largely unknown. We …
postulated; however, until recently, the molecular components were largely unknown. We …
[PDF][PDF] Early introductions and transmission of SARS-CoV-2 variant B. 1.1. 7 in the United States
…, A Russell, JP Kelly, M Shudt, J Plitnick, E Schneider… - Cell, 2021 - cell.com
The emergence and spread of SARS-CoV-2 lineage B.1.1.7, first detected in the United
Kingdom, has become a global public health concern because of its increased transmissibility. …
Kingdom, has become a global public health concern because of its increased transmissibility. …
Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF7 cell line selected …
E Schneider, JK Horton, CH Yang, M Nakagawa… - Cancer research, 1994 - AACR
A human breast cancer cell line (MCF7/WT) was selected for resistance to etoposide (VP-16)
by stepwise exposure to 2-fold increasing concentrations of this agent. The resulting cell …
by stepwise exposure to 2-fold increasing concentrations of this agent. The resulting cell …
The product of the ABC half-transporter gene ABCG2 (BCRP/MXR/ABCP) is expressed in the plasma membrane
…, CH Yang, T Litman, SE Bates, E Schneider - Biochemical and …, 2000 - Elsevier
The products of the ABC gene family can be generally classified as either full-transporters of
half-transporters. Full-transporters are expressed in the plasma membrane, whereas half-…
half-transporters. Full-transporters are expressed in the plasma membrane, whereas half-…
Reduced Intracellular Drug Accumulation in the Absence of P-Glycoprotein (mdr1) Overexpression in Mitoxantrone-resistant Human MCF-7 Breast Cancer Cells
M Nakagawa, E Schneider, KH Dixon, J Horton… - Cancer research, 1992 - AACR
A mitoxantrone-resistant human MCF-7 breast cancer subline (MCF/MX) which is approximately
4000-fold resistant to mitoxantrone was isolated by serial passage of the parental wild-…
4000-fold resistant to mitoxantrone was isolated by serial passage of the parental wild-…
Notch1 regulates the expression of the multidrug resistance gene ABCC1/MRP1 in cultured cancer cells
…, X He, PLR Ee, U Bhat, E Schneider… - Proceedings of the …, 2011 - National Acad Sciences
Multidrug resistance (MDR) is a barrier to successful cancer chemotherapy. Although MDR
is associated with overexpression of ATP-binding cassette (ABC) membrane transporters, …
is associated with overexpression of ATP-binding cassette (ABC) membrane transporters, …
Coordinated action of glutathione S-transferases (GSTs) and multidrug resistance protein 1 (MRP1) in antineoplastic drug detoxification: mechanism of GST A1-1-and …
…, PK Smitherman, SK Diah, E Schneider… - Journal of Biological …, 1998 - ASBMB
To examine the role of multidrug resistance protein 1 (MRP1) and glutathione S-transferases
(GSTs) in cellular resistance to antineoplastic drugs, derivatives of MCF7 breast carcinoma …
(GSTs) in cellular resistance to antineoplastic drugs, derivatives of MCF7 breast carcinoma …
DNA topoisomerases as anticancer drug targets
E Schneider, YH Hsiang, LF Liu - Advances in pharmacology, 1990 - Elsevier
Publisher Summary This chapter discusses the DNA topoisomerases as anticancer drug
targets. Much progress has been made in recent years in understanding the mechanism of …
targets. Much progress has been made in recent years in understanding the mechanism of …
